Abstract
Experimental modeling of human inherited disorders provides insight into the cellular and molecular mechanisms involved, and the underlying genetic component influencing, the disease phenotype. The breakthrough development of induced pluripotent stem cell (iPSC) technology represents a quantum leap in experimental modeling of human diseases, providing investigators with a self-renewing and, thus, unlimited source of pluripotent cells for targeted differentiation. In principle, the entire range of cell types found in the human body can be interrogated using an iPSC approach. Therefore, iPSC technology, and the increasingly refined abilities to differentiate iPSCs into disease-relevant target cells, has far-reaching implications for understanding disease pathophysiology, identifying disease-causing genes, and developing more precise therapeutics, including advances in regenerative medicine. In this chapter, we discuss the technological perspectives and recent developments in the application of patient-derived iPSC lines for human disease modeling and disease gene identification.
Similar content being viewed by others
References
Lander ES (2011) Initial impact of the sequencing of the human genome. Nature 470(7333):187–197. https://doi.org/10.1038/nature09792
Handley A, Schauer T, Ladurner AG et al (2015) Designing cell-type-specific genome-wide experiments. Mol Cell 58(4):621–631. https://doi.org/10.1016/j.molcel.2015.04.024
Phillips KA, Bales KL, Capitanio JP et al (2014) Why primate models matter. Am J Primatol 76(9):801–827. https://doi.org/10.1002/ajp.22281
Seok J, Warren HS, Cuenca AG et al (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110(9):3507–3512. https://doi.org/10.1073/pnas.1222878110
Springer MS, Murphy WJ, Eizirik E et al (2003) Placental mammal diversification and the cretaceous-tertiary boundary. Proc Natl Acad Sci U S A 100(3):1056–1061. https://doi.org/10.1073/pnas.0334222100
Masters JR, Stacey GN (2007) Changing medium and passaging cell lines. Nat Protoc 2(9):2276–2284
Min JL, Barrett A, Watts T et al (2010) Variability of gene expression profiles in human blood and lymphoblastoid cell lines. BMC Genomics 11:96. https://doi.org/10.1186/1471-2164-11-96
Caliskan M, Cusanovich DA, Ober C et al (2011) The effects of EBV transformation on gene expression levels and methylation profiles. Hum Mol Genet 20(8):1643–1652. https://doi.org/10.1093/hmg/ddr041
Nestor CE, Ottaviano R, Reinhardt D et al (2015) Rapid reprogramming of epigenetic and transcriptional profiles in mammalian culture systems. Genome Biol 16:11. https://doi.org/10.1186/s13059-014-0576-y
Horvath P, Aulner N, Bickle M et al (2016) Screening out irrelevant cell-based models of disease. Nat Rev Drug Discov 15(11):751–769. https://doi.org/10.1038/nrd.2016.175
Avior Y, Sagi I, Benvenisty N (2016) Pluripotent stem cells in disease modelling and drug discovery. Nat Rev Mol Cell Biol 17(3):170–182. https://doi.org/10.1038/nrm.2015.27
Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292(5819):154–156
Thomson JA, Itskovitz-Eldor J, Shapiro SS et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145–1147
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676
Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861–872
Yu J, Vodyanik MA, Smuga-Otto K et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917–1920
Park IH, Zhao R, West JA et al (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451(7175):141–146
Aasen T, Raya A, Barrero MJ et al (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26(11):1276–1284. https://doi.org/10.1038/nbt.1503
Hanna J, Markoulaki S, Schorderet P et al (2008) Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133(2):250–264. https://doi.org/10.1016/j.cell.2008.03.028
Utikal J, Maherali N, Kulalert W et al (2009) Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci 122(Pt 19):3502–3510. https://doi.org/10.1242/jcs.054783
Carette JE, Pruszak J, Varadarajan M et al (2010) Generation of iPSCs from cultured human malignant cells. Blood 115(20):4039–4042. https://doi.org/10.1182/blood-2009-07-231845
Miyoshi N, Ishii H, Nagai K et al (2010) Defined factors induce reprogramming of gastrointestinal cancer cells. Proc Natl Acad Sci U S A 107(1):40–45. https://doi.org/10.1073/pnas.0912407107
Seki T, Yuasa S, Oda M et al (2010) Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7(1):11–14. https://doi.org/10.1016/j.stem.2010.06.003
Tsai SY, Clavel C, Kim S et al (2010) Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells. Stem Cells 28(2):221–228. https://doi.org/10.1002/stem.281
Kim J, Lengner CJ, Kirak O et al (2011) Reprogramming of postnatal neurons into induced pluripotent stem cells by defined factors. Stem Cells 29(6):992–1000. https://doi.org/10.1002/stem.641
Kumar S, Curran JE, Glahn DC et al (2016) Utility of lymphoblastoid cell lines for induced pluripotent stem cell generation. Stem Cells Int 2016:2349261. https://doi.org/10.1155/2016/2349261
Rubin LL (2008) Stem cells and drug discovery: the beginning of a new era? Cell 132(4):549–552. https://doi.org/10.1016/j.cell.2008.02.010
Maehr R, Chen S, Snitow M et al (2009) Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A 106(37):15768–15773. https://doi.org/10.1073/pnas.0906894106
Chun YS, Chaudhari P, Jang YY (2010) Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease. Int J Biol Sci 6(7):796–805
Ghodsizadeh A, Taei A, Totonchi M et al (2010) Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells. Stem Cell Rev 6(4):622–632. https://doi.org/10.1007/s12015-010-9189-3
Rashid ST, Corbineau S, Hannan N et al (2010) Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest 120(9):3127–3136. https://doi.org/10.1172/JCI43122
Rosenzweig A (2010) Illuminating the potential of pluripotent stem cells. N Engl J Med 363(15):1471–1472. https://doi.org/10.1056/NEJMe1007902
Yoshida Y, Yamanaka S (2010) Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration. Circulation 122(1):80–87. https://doi.org/10.1161/CIRCULATIONAHA.109.881433
Zhang N, An MC, Montoro D et al (2010) Characterization of human Huntington’s disease cell model from induced pluripotent stem cells. PLoS Curr 2:RRN1193. https://doi.org/10.1371/currents.RRN1193
Brennand KJ, Simone A, Jou J et al (2011) Modelling schizophrenia using human induced pluripotent stem cells. Nature 473(7346):221–225. https://doi.org/10.1038/nature09915
Kondo T, Asai M, Tsukita K et al (2013) Modeling Alzheimer’s disease with iPSCs reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness. Cell Stem Cell 12(4):487–496. https://doi.org/10.1016/j.stem.2013.01.009
Liang P, Du J (2014) Human induced pluripotent stem cell for modeling cardiovascular diseases. Regen Med Res 2(1):4. https://doi.org/10.1186/2050-490X-2-4
Brennand K, Savas JN, Kim Y et al (2015) Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol Psychiatry 20(3):361–368. https://doi.org/10.1038/mp.2014.22
NIMH-RGR Data Explorer (2015) NIMH Repository and Genomics Resource, USA. https://explorer.nimhgenetics.org/. Accessed 14 Oct 2015
Okita K, Yamakawa T, Matsumura Y et al (2013) An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 31(3):458–466. https://doi.org/10.1002/stem.1293
Rajesh D, Dickerson SJ, Yu J et al (2011) Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells. Blood 118(7):1797–1800. https://doi.org/10.1182/blood-2011-01-332064
Choi SM, Liu H, Chaudhari P et al (2011) Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells. Blood 118(7):1801–1805. https://doi.org/10.1182/blood-2011-03-340620
Roe T, Reynolds TC, Yu G et al (1993) Integration of murine leukemia virus DNA depends on mitosis. EMBO J 12(5):2099–2108
Bukrinsky MI, Sharova N, Dempsey MP et al (1992) Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci U S A 89(14):6580–6584
Medvedev SP, Shevchenko AI, Zakian SM (2010) Induced pluripotent stem cells: problems and advantages when applying them in regenerative medicine. Acta Nat 2(2):18–28
Rao MS, Malik N (2012) Assessing iPSC reprogramming methods for their suitability in translational medicine. J Cell Biochem 113(10):3061–3068. https://doi.org/10.1002/jcb.24183
Chang CW, Lai YS, Pawlik KM et al (2009) Polycistronic lentiviral vector for “hit and run” reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells 27(5):1042–1049. https://doi.org/10.1002/stem.39
Soldner F, Hockemeyer D, Beard C et al (2009) Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136(5):964–977. https://doi.org/10.1016/j.cell.2009.02.013
Sommer CA, Stadtfeld M, Murphy GJ et al (2009) Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 27(3):543–549. https://doi.org/10.1634/stemcells.2008-1075
Somers A, Jean JC, Sommer CA et al (2010) Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells 28(10):1728–1740. https://doi.org/10.1002/stem.495
KUROYA M, ISHIDA N (1953) Newborn virus pneumonitis (type Sendai). II. The isolation of a new virus possessing hemagglutinin activity. Yokohama Med Bull 4(4):217–233
Fusaki N, Ban H, Nishiyama A et al (2009) Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85(8):348–362
Ban H, Nishishita N, Fusaki N et al (2011) Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci U S A 108(34):14234–14239. https://doi.org/10.1073/pnas.1103509108
Schlaeger TM, Daheron L, Brickler TR et al (2015) A comparison of non-integrating reprogramming methods. Nat Biotechnol 33(1):58–63. https://doi.org/10.1038/nbt.3070
Sun TQ, Fenstermacher DA, Vos JM (1994) Human artificial episomal chromosomes for cloning large DNA fragments in human cells. Nat Genet 8(1):33–41. https://doi.org/10.1038/ng0994-33
Simpson K, McGuigan A, Huxley C (1996) Stable episomal maintenance of yeast artificial chromosomes in human cells. Mol Cell Biol 16(9):5117–5126
Westphal EM, Sierakowska H, Livanos E et al (1998) A system for shuttling 200-kb BAC/PAC clones into human cells: stable extrachromosomal persistence and long-term ectopic gene activation. Hum Gene Ther 9(13):1863–1873. https://doi.org/10.1089/hum.1998.9.13-1863
Yu J, Hu K, Smuga-Otto K et al (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324(5928):797–801. https://doi.org/10.1126/science.1172482
Hu K, Yu J, Suknuntha K et al (2011) Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood 117(14):e109–e119. https://doi.org/10.1182/blood-2010-07-298331
Lin T, Ambasudhan R, Yuan X et al (2009) A chemical platform for improved induction of human iPSCs. Nat Methods 6(11):805–808. https://doi.org/10.1038/nmeth.1393
Yu J, Chau KF, Vodyanik MA et al (2011) Efficient feeder-free episomal reprogramming with small molecules. PLoS One 6(3):e17557. https://doi.org/10.1371/journal.pone.0017557
Chou BK, Mali P, Huang X et al (2011) Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 21(3):518–529. https://doi.org/10.1038/cr.2011.12
Okita K, Matsumura Y, Sato Y et al (2011) A more efficient method to generate integration-free human iPS cells. Nat Methods 8(5):409–412. https://doi.org/10.1038/nmeth.1591
Warren L, Manos PD, Ahfeldt T et al (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7(5):618–630. https://doi.org/10.1016/j.stem.2010.08.012
Goh PA, Caxaria S, Casper C et al (2013) A systematic evaluation of integration free reprogramming methods for deriving clinically relevant patient specific induced pluripotent stem (iPS) cells. PLoS One 8(11):e81622. https://doi.org/10.1371/journal.pone.0081622
Warren L, Ni Y, Wang J et al (2012) Feeder-free derivation of human induced pluripotent stem cells with messenger RNA. Sci Rep 2:657. https://doi.org/10.1038/srep00657
Merkle FT, Eggan K (2013) Modeling human disease with pluripotent stem cells: from genome association to function. Cell Stem Cell 12(6):656–668. https://doi.org/10.1016/j.stem.2013.05.016
Kajiwara M, Aoi T, Okita K et al (2012) Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci U S A 109(31):12538–12543. https://doi.org/10.1073/pnas.1209979109
Mills JA, Wang K, Paluru P et al (2013) Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell lines. Blood 122(12):2047–2051. https://doi.org/10.1182/blood-2013-02-484444
Shao K, Koch C, Gupta MK et al (2013) Induced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profiles. Mol Ther 21(1):240–250. https://doi.org/10.1038/mt.2012.207
Rouhani F, Kumasaka N, de Brito MC et al (2014) Genetic background drives transcriptional variation in human induced pluripotent stem cells. PLoS Genet 10(6):e1004432. https://doi.org/10.1371/journal.pgen.1004432
Kyttala A, Moraghebi R, Valensisi C et al (2016) Genetic variability overrides the impact of parental cell type and determines iPSC differentiation potential. Stem Cell Rep 6(2):200–212. https://doi.org/10.1016/j.stemcr.2015.12.009
Bock C, Kiskinis E, Verstappen G et al (2011) Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144(3):439–452. https://doi.org/10.1016/j.cell.2010.12.032
Boulting GL, Kiskinis E, Croft GF et al (2011) A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol 29(3):279–286. https://doi.org/10.1038/nbt.1783
HD iPSC Consortium (2012) Induced pluripotent stem cells from patients with Huntington’s disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 11(2):264–278. https://doi.org/10.1016/j.stem.2012.04.027
Cohen DE, Melton D (2011) Turning straw into gold: directing cell fate for regenerative medicine. Nat Rev Genet 12(4):243–252. https://doi.org/10.1038/nrg2938
Williams LA, Davis-Dusenbery BN, Eggan KC (2012) SnapShot: directed differentiation of pluripotent stem cells. Cell 149(5):1174–1174.e1. https://doi.org/10.1016/j.cell.2012.05.015
Lian X, Zhang J, Azarin SM et al (2013) Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions. Nat Protoc 8(1):162–175. https://doi.org/10.1038/nprot.2012.150
Yan Y, Shin S, Jha BS et al (2013) Efficient and rapid derivation of primitive neural stem cells and generation of brain subtype neurons from human pluripotent stem cells. Stem Cells Transl Med 2(11):862–870. https://doi.org/10.5966/sctm.2013-0080
Carlson C, Koonce C, Aoyama N et al (2013) Phenotypic screening with human iPS cell-derived cardiomyocytes: HTS-compatible assays for interrogating cardiac hypertrophy. J Biomol Screen 18(10):1203–1211. https://doi.org/10.1177/1087057113500812
Drawnel FM, Boccardo S, Prummer M et al (2014) Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells. Cell Rep 9(3):810–821. https://doi.org/10.1016/j.celrep.2014.09.055
Slukvin II, Vodyanik MA, Thomson JA et al (2006) Directed differentiation of human embryonic stem cells into functional dendritic cells through the myeloid pathway. J Immunol 176(5):2924–2932
Erceg S, Lainez S, Ronaghi M et al (2008) Differentiation of human embryonic stem cells to regional specific neural precursors in chemically defined medium conditions. PLoS One 3(5):e2122. https://doi.org/10.1371/journal.pone.0002122
Prigodich AE, Seferos DS, Massich MD et al (2009) Nano-flares for mRNA regulation and detection. ACS Nano 3(8):2147–2152. https://doi.org/10.1021/nn9003814
Larsson HM, Lee ST, Roccio M et al (2012) Sorting live stem cells based on Sox2 mRNA expression. PLoS One 7(11):e49874. https://doi.org/10.1371/journal.pone.0049874
Tohyama S, Hattori F, Sano M et al (2013) Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 12(1):127–137. https://doi.org/10.1016/j.stem.2012.09.013
Nguyen HN, Byers B, Cord B et al (2011) LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8(3):267–280. https://doi.org/10.1016/j.stem.2011.01.013
Israel MA, Yuan SH, Bardy C et al (2012) Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells. Nature 482(7384):216–220. https://doi.org/10.1038/nature10821
Reinhardt P, Schmid B, Burbulla LF et al (2013) Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell 12(3):354–367. https://doi.org/10.1016/j.stem.2013.01.008
Ieda M, JD F, Delgado-Olguin P et al (2010) Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142(3):375–386. https://doi.org/10.1016/j.cell.2010.07.002
Szabo E, Rampalli S, Risueno RM et al (2010) Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468(7323):521–526. https://doi.org/10.1038/nature09591
Vierbuchen T, Ostermeier A, Pang ZP et al (2010) Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463(7284):1035–1041. https://doi.org/10.1038/nature08797
Sekiya S, Suzuki A (2011) Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 475(7356):390–393. https://doi.org/10.1038/nature10263
Ring KL, Tong LM, Balestra ME et al (2012) Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. Cell Stem Cell 11(1):100–109. https://doi.org/10.1016/j.stem.2012.05.018
Vierbuchen T, Wernig M (2011) Direct lineage conversions: unnatural but useful? Nat Biotechnol 29(10):892–907. https://doi.org/10.1038/nbt.1946
Yang C, Al-Aama J, Stojkovic M et al (2015) Concise review: cardiac disease modeling using induced pluripotent stem cells. Stem Cells 33(9):2643–2651. https://doi.org/10.1002/stem.2070
Nishi M, Akutsu H, Kudoh A et al (2014) Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell. Oncotarget 5(18):8665–8680
Curry EL, Moad M, Robson CN et al (2015) Using induced pluripotent stem cells as a tool for modelling carcinogenesis. World J Stem Cells 7(2):461–469. https://doi.org/10.4252/wjsc.v7.i2.461
Wiley LA, Burnight ER, Songstad AE et al (2015) Patient-specific induced pluripotent stem cells (iPSCs) for the study and treatment of retinal degenerative diseases. Prog Retin Eye Res 44:15–35. https://doi.org/10.1016/j.preteyeres.2014.10.002
Zheng A, Li Y, Tsang SH (2015) Personalized therapeutic strategies for patients with retinitis pigmentosa. Expert Opin Biol Ther 15(3):391–402. https://doi.org/10.1517/14712598.2015.1006192
Lysy PA, Weir GC, Bonner-Weir S (2012) Concise review: pancreas regeneration: recent advances and perspectives. Stem Cells Transl Med 1(2):150–159. https://doi.org/10.5966/sctm.2011-0025
Abdelalim EM, Bonnefond A, Bennaceur-Griscelli A et al (2014) Pluripotent stem cells as a potential tool for disease modelling and cell therapy in diabetes. Stem Cell Rev 10(3):327–337. https://doi.org/10.1007/s12015-014-9503-6
Peitz M, Jungverdorben J, Brustle O (2013) Disease-specific iPS cell models in neuroscience. Curr Mol Med 13(5):832–841
Crook JM, Wallace G, Tomaskovic-Crook E (2015) The potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapy. Expert Rev Neurother 15(3):295–304. https://doi.org/10.1586/14737175.2015.1013096
Goring HH, Curran JE, Johnson MP et al (2007) Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes. Nat Genet 39(10):1208–1216. https://doi.org/10.1038/ng2119
Winnier DA, Fourcaudot M, Norton L et al (2015) Transcriptomic identification of ADH1B as a novel candidate gene for obesity and insulin resistance in human adipose tissue in Mexican Americans from the Veterans Administration Genetic Epidemiology Study (VAGES). PLoS One 10(4):e0119941. https://doi.org/10.1371/journal.pone.0119941
Pasca SP, Portmann T, Voineagu I et al (2011) Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat Med 17(12):1657–1662. https://doi.org/10.1038/nm.2576
Prilutsky D, Palmer NP, Smedemark-Margulies N et al (2014) iPSC-derived neurons as a higher-throughput readout for autism: promises and pitfalls. Trends Mol Med 20(2):91–104. https://doi.org/10.1016/j.molmed.2013.11.004
Wen Z, Nguyen HN, Guo Z et al (2014) Synaptic dysregulation in a human iPS cell model of mental disorders. Nature 515(7527):414–418. https://doi.org/10.1038/nature13716
Farra N, Zhang WB, Pasceri P et al (2012) Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations. Mol Psychiatry 17(12):1261–1271. https://doi.org/10.1038/mp.2011.180
Vaccarino FM, Urban AE, Stevens HE et al (2011) Annual research review: the promise of stem cell research for neuropsychiatric disorders. J Child Psychol Psychiatry 52(4):504–516. https://doi.org/10.1111/j.1469-7610.2010.02348.x
Vaccarino FM, Stevens HE, Kocabas A et al (2011) Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders. Neuropharmacology 60(7-8):1355–1363. https://doi.org/10.1016/j.neuropharm.2011.02.021
Stevens HE, Mariani J, Coppola G et al (2012) Neurobiology meets genomic science: the promise of human-induced pluripotent stem cells. Dev Psychopathol 24(4):1443–1451. https://doi.org/10.1017/S095457941200082X
Chae JI, Kim DW, Lee N et al (2012) Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington’s disease patient. Biochem J 446(3):359–371. https://doi.org/10.1042/BJ20111495
Szlachcic WJ, Switonski PM, Krzyzosiak WJ et al (2015) Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway. Dis Model Mech 8(9):1047–1057. https://doi.org/10.1242/dmm.019406
Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44(7):660–669
White T, Anjum A, Schulz SC (2006) The schizophrenia prodrome. Am J Psychiatry 163(3):376–380
Gulsuner S, Walsh T, Watts AC et al (2013) Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 154(3):518–529. https://doi.org/10.1016/j.cell.2013.06.049
Mariani J, Simonini MV, Palejev D et al (2012) Modeling human cortical development in vitro using induced pluripotent stem cells. Proc Natl Acad Sci U S A 109(31):12770–12775. https://doi.org/10.1073/pnas.1202944109
Nicholas CR, Chen J, Tang Y et al (2013) Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development. Cell Stem Cell 12(5):573–586. https://doi.org/10.1016/j.stem.2013.04.005
Espuny-Camacho I, Michelsen KA, Gall D et al (2013) Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo. Neuron 77(3):440–456. https://doi.org/10.1016/j.neuron.2012.12.011
Maroof AM, Keros S, Tyson JA et al (2013) Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell 12(5):559–572. https://doi.org/10.1016/j.stem.2013.04.008
Hu BY, Du ZW, Zhang SC (2009) Differentiation of human oligodendrocytes from pluripotent stem cells. Nat Protoc 4(11):1614–1622. https://doi.org/10.1038/nprot.2009.186
Wang S, Bates J, Li X et al (2013) Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 12(2):252–264. https://doi.org/10.1016/j.stem.2012.12.002
Kim C, Wong J, Wen J et al (2013) Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature 494(7435):105–110. https://doi.org/10.1038/nature11799
Maher B (2008) Personal genomes: the case of the missing heritability. Nature 456(7218):18–21. https://doi.org/10.1038/456018a
Manolio TA, Collins FS, Cox NJ et al (2009) Finding the missing heritability of complex diseases. Nature 461(7265):747–753. https://doi.org/10.1038/nature08494; 10.1038/nature08494
Franke A, McGovern DP, Barrett JC et al (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet 42(12):1118–1125. https://doi.org/10.1038/ng.717
Cardno AG, Gottesman II (2000) Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 97(1):12–17. https://doi.org/10.1002/(SICI)1096-8628(200021)97:13.0.CO;2-U[pii]
Sullivan PF, Kendler KS, Neale MC (2003) Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60(12):1187–1192. https://doi.org/10.1001/archpsyc.60.12.1187
Visscher PM, Goddard ME, Derks EM et al (2012) Evidence-based psychiatric genetics, AKA the false dichotomy between common and rare variant hypotheses. Mol Psychiatry 17(5):474–485. https://doi.org/10.1038/mp.2011.65
McGuire SE, McGuire AL (2008) Don’t throw the baby out with the bathwater: enabling a bottom-up approach in genome-wide association studies. Genome Res 18(11):1683–1685. https://doi.org/10.1101/gr.083584.108
Tracy RP (2008) ‘Deep phenotyping’: characterizing populations in the era of genomics and systems biology. Curr Opin Lipidol 19(2):151–157. https://doi.org/10.1097/MOL.0b013e3282f73893
Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408(6810):307–310. https://doi.org/10.1038/35042675
Chao EC, Lipkin SM (2006) Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis. Nucleic Acids Res 34(3):840–852
Goh KI, Cusick ME, Valle D et al (2007) The human disease network. Proc Natl Acad Sci U S A 104(21):8685–8690
Lage K, Hansen NT, Karlberg EO et al (2008) A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes. Proc Natl Acad Sci U S A 105(52):20870–20875. https://doi.org/10.1073/pnas.0810772105
Barshir R, Shwartz O, Smoly IY et al (2014) Comparative analysis of human tissue interactomes reveals factors leading to tissue-specific manifestation of hereditary diseases. PLoS Comput Biol 10(6):e1003632. https://doi.org/10.1371/journal.pcbi.1003632
Jenkinson CP, Goring HH, Arya R et al (2015) Transcriptomics in type 2 diabetes: bridging the gap between genotype and phenotype. Genom Data 8:25–36. https://doi.org/10.1016/j.gdata.2015.12.001
Kim H, Kim JS (2014) A guide to genome engineering with programmable nucleases. Nat Rev Genet 15(5):321–334. https://doi.org/10.1038/nrg3686
Boch J, Scholze H, Schornack S et al (2009) Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326(5959):1509–1512. https://doi.org/10.1126/science.1178811
Wood AJ, Lo TW, Zeitler B et al (2011) Targeted genome editing across species using ZFNs and TALENs. Science 333(6040):307. https://doi.org/10.1126/science.1207773
Sanjana NE, Cong L, Zhou Y et al (2012) A transcription activator-like effector toolbox for genome engineering. Nat Protoc 7(1):171–192. https://doi.org/10.1038/nprot.2011.431
Cong L, Ran FA, Cox D et al (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339(6121):819–823. https://doi.org/10.1126/science.1231143
Mali P, Yang L, Esvelt KM et al (2013) RNA-guided human genome engineering via Cas9. Science 339(6121):823–826. https://doi.org/10.1126/science.1232033
Carroll D, Morton JJ, Beumer KJ et al (2006) Design, construction and in vitro testing of zinc finger nucleases. Nat Protoc 1(3):1329–1341
Miller JC, Tan S, Qiao G et al (2011) A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 29(2):143–148. https://doi.org/10.1038/nbt.1755
Jinek M, Chylinski K, Fonfara I et al (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096):816–821. https://doi.org/10.1126/science.1225829
Musunuru K (2013) Genome editing of human pluripotent stem cells to generate human cellular disease models. Dis Model Mech 6(4):896–904. https://doi.org/10.3824/stembook.1.94.1
Lombardo A, Genovese P, Beausejour CM et al (2007) Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol 25(11):1298–1306
Suzuki K, Mitsui K, Aizawa E et al (2008) Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors. Proc Natl Acad Sci U S A 105(37):13781–13786. https://doi.org/10.1073/pnas.0806976105
Zou J, Maeder ML, Mali P et al (2009) Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 5(1):97–110. https://doi.org/10.1016/j.stem.2009.05.023
Hockemeyer D, Wang H, Kiani S et al (2011) Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 29(8):731–734. https://doi.org/10.1038/nbt.1927
Li M, Suzuki K, Qu J et al (2011) Efficient correction of hemoglobinopathy-causing mutations by homologous recombination in integration-free patient iPSCs. Cell Res 21(12):1740–1744. https://doi.org/10.1038/cr.2011.186
Sebastiano V, Maeder ML, Angstman JF et al (2011) In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases. Stem Cells 29(11):1717–1726. https://doi.org/10.1002/stem.718
Soldner F, Laganiere J, Cheng AW et al (2011) Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 146(2):318–331. https://doi.org/10.1016/j.cell.2011.06.019
Yusa K, Rashid ST, Strick-Marchand H et al (2011) Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells. Nature 478(7369):391–394. https://doi.org/10.1038/nature10424
Zou J, Mali P, Huang X et al (2011) Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. Blood 118(17):4599–4608. https://doi.org/10.1182/blood-2011-02-335554
Lan F, Lee AS, Liang P et al (2013) Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell 12(1):101–113. https://doi.org/10.1016/j.stem.2012.10.010
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Kumar, S., Blangero, J., Curran, J.E. (2018). Induced Pluripotent Stem Cells in Disease Modeling and Gene Identification. In: DiStefano, J. (eds) Disease Gene Identification. Methods in Molecular Biology, vol 1706. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7471-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7471-9_2
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7470-2
Online ISBN: 978-1-4939-7471-9
eBook Packages: Springer Protocols